LEA Partners

Investor ● Covered in 1 story + Follow ✴ AI Graph

This profile is built automatically from TLDRocket coverage.

Signals

1 story (new)

Media momentum

As of 27 Oct 2026 · Visible stories in the last 30 days, compared with the 30 days before.

1 source

Source diversity

As of 27 Oct 2026 · Distinct publications behind this entity's visible coverage.

1 investment

Investment activity

As of 27 Oct 2026 · Source-backed invests-in relationships tracked from this investor.

Oct 2026

Coverage span

As of 27 Oct 2026 · First to most recent month of TLDRocket coverage of this entity.

Management

updated 27 Oct 2026

Sebastian Mueller Managing Partner
Johannes Weide Limited Partner
Clemens Weidenbach Partner
Nicole Kerschl Chief People Officer
Joachim Masurek Head of IR & Capital Formation
Martin Trenkle Partner
Luis Frey Investment Manager
Niklas K. Investment Manager
Manuel Künzig Investment Manager
Kilian Mayer Investment Manager
Jan Huber Investment Manager
Alexi Malikotsinas Principal

+ 5 more tracked

Portfolio

Atlas Bio

Latest developments

Swiss startup Atlas Bio secures $12.5M to tackle drug development’s 70% failure rate and move beyond animal testing Tech.eu · 3 hours ago · 41

Timeline

Month Quarter Year

October 2026

LEA Partners invests in Atlas Bio Funding

Atlas Bio raises $12.5 million to develop AI simulations for in silico drug trials during Phase II studies Funding

27 Oct Swiss startup Atlas Bio secures $12.5M to tackle drug development’s 70% failure rate and move beyond animal testing

Relationships

Investment & ownership

Invests in Atlas Bio · 1 source

Every AI story that matters,
in your inbox by 8am.

TLDRocket reads all relevant sources, removes duplicate coverage, and summarises the day in two minutes. Follow companies and topics for alerts, or get the briefing in Slack. Free, no spam, unsubscribe anytime.